A new study of measuring blood pressure at home in U.S. populations has found that the ideal level is 130 over 80 or lower.
• Within one year after initiating dialysis, patients on more frequent home hemodialysis were 23% less likely to die compared with patients receiving traditional in-center hemodialysis. • Results from the study will be presented at ASN Kidney Week 2018 October 23–October 28 at the San Diego Convention Center.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23–October 28 at the San Diego Convention Center.
In this issue, find research on infant sugary drink consumption, China's top 20 health challenges, aging and healthy years in the Netherlands, and increasing opioid use in Massachusetts
Multiple myeloma doesn’t play around. Within five years of being diagnosed with this form of blood cancer, about half of all patients die from it. And even if they initially respond well to treatment, the cancer can hide in their bone marrow for years before reemerging in a tougher-to-treat form.
Researchers at McMaster University have solved a vexing problem by engineering surface coatings that can repel everything, such as bacteria, viruses and living cells, but can be modified to permit beneficial exceptions.
New findings raise the possibility of a novel treatment for this subtype of blood and bone marrow cancer – known as acute myeloid leukemia or AML – by attacking a harmful molecule found on the cancerous cells and also reactivating the body’s white blood cells to fight them.
For diabetics, managing high blood pressure may help to prevent life-threatening organ damage according to a Rutgers study. The study findings suggests that extremely high blood pressure, not just diabetes, is responsible for severe organ damage due to hypertensive emergencies in African-Americans with diabetes.
The Association of American Cancer Institutes (AACI) has established a national initiative to advance the use of chimeric antigen receptor T-cell therapies (CAR T). Joseph McGuirk, DO, division director of the Hematologic Malignancies and Cellular Therapeutics program at The University of Kansas Cancer Center, is leading the effort.
Despite the existence of chemical-free methods to eradicate pests, Americans use more than a billion pounds of pesticides per year. These chemicals are mostly out of sight and out of mind to unsuspecting homeowners, who are typically unaware of how to prevent potential harm – something new Cornell University research is addressing.
Researchers will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology in San Antonio on Tuesday, Oct. 23, from a study evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma.
Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself. Instead, any negative changes to clinical results are more likely due to decreased blood flow.
new program project grant from the National Cancer Institute (NCI) will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of Pennsylvania to improve the effectiveness of chimeric antigen receptor (CAR) T cell therapy at fighting solid tumors.
When it comes to preventing blood clots after a knee replacement, good old aspirin may be just as effective as newer, more expensive drugs, such as rivaroxaban (Xarelto), according to a study by University of Michigan orthopedic surgeons.
New research at the 2018 ACR/ARHP Annual Meeting builds on current evidence that hematopoietic stem cell transplantation can significantly improve long-term outcomes for patients with severe scleroderma when compared to use of conventional treatment with cyclophosphamide.
The 2018 American College of Rheumatology/American Rheumatology Health Professionals Annual Meeting.
Data on the molecular makeup and drug sensitivity of hundreds of patient samples could accelerate progress against the aggressive blood cancer acute myeloid leukemia.
Women who experience high blood pressure prior to labor may be more likely to deliver babies with a lower Apgar score, a measure of a newborn’s physical health, suggests new research presented at the ANESTHESIOLOGY® 2018 annual meeting.
Johns Hopkins students will be presenting posters of their engineering projects designed to fill needs in clinical care
Mayo Clinic的研究人员已经确定了三种特定的基因类型，这些基因类型会使非洲裔美国人的骨髓瘤（myeloma）诊断增加两到三倍。 研究人员还展示了DNA分析在更准确地研究种族和种族混合上的效果。 该研究结果发表在《血癌学杂志》（Blood Cancer Journal）上。
Pesquisadores da Mayo Clinic identificaram três tipos de genes específicos que explicam um aumento conhecido de duas a três vezes no diagnóstico de mieloma entre afro-americanos. Os pesquisadores também demonstraram a capacidade de estudar raça e mistura racial com mais precisão usando análise de DNA. As descobertas foram publicadas no periódico Blood Cancer Journal.
Los científicos de Mayo Clinic identificaron tres tipos específicos de genes a los que se atribuye el aumento al triple de los diagnósticos de mieloma entre los afroamericanos. Los científicos también demostraron que se puede estudiar la raza y el mestizaje con el análisis del ADN.
Ronald Paquette, MD, clinical director of the Cedars-Sinai Blood & Marrow Transplant Program at the Samuel Oschin Comprehensive Cancer Institute, recently was accepted as a member of the Myeloproliferative Neoplasm Research Consortium. The group is funded by the National Cancer Institute.
• Certain parameters measured by ultrasound helped predict the success of an arteriovenous fistula, the preferred type of hemodialysis vascular access, in individual patients.
BOSTON – (October 10, 2018) – Type 2 diabetes is driven by many metabolic pathways, with some pathways driven by amino acids, the molecular building blocks for proteins. Scientists at Joslin Diabetes Center now have shown that one amino acid, alanine, may produce a short-term lowering of glucose levels by altering energy metabolism in the cell.
Sepsis remains a common and deadly condition that occurs when the body reacts to an infection in the bloodstream. However, scientists know little about the early stages of the condition. Now, researchers from Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC Santa Barbara have discovered that host responses during sepsis progression can vary in important ways based on pathogen type—which could lead to more effective treatments. The study published today in Cell Host and Microbe.
A UPMC-developed test for diagnosis of thyroid nodules, ThyroSeq® Genomic Classifier, has been approved for coverage by its Medicare Administrative Contractor, Novitas Solutions. This decision paves the way for the test to be accessible to more than 50 million Medicare patients nationwide.
ROCHESTER Minn. — Researchers at Mayo Clinic have identified three specific gene types that account for a known two-to-three-fold increase in myeloma diagnoses among African-Americans. Researchers also demonstrated the ability to study race and racial admixture more accurately using DNA analysis. The findings were published today in Blood Cancer Journal.
Using a statistical technique called network meta-analysis, researchers have combined the results of dozens of studies of dietary oils to identify those with the best effect on patients' LDL cholesterol and other blood lipids.
Pediatric researchers studying the life-threatening blood disorder Fanconi anemia have devised a method to block the abnormal biological signals that drive the disease. This proof-of-concept finding in animals and stem cells may lay the foundation for better treatments for children with the rare, frequently fatal disease.
Lifestyle intervention delivered in churches by community-based health workers led to a significant reduction in blood pressure among African Americans compared to health education alone, according to a study led by researchers at NYU School of Medicine publishing online October 9 in the journal Circulation: Cardiovascular Quality and Outcomes.
The phase II study was led by researchers at The University of Texas MD Anderson Cancer Center. Results of the study, the first randomized neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients, are reported in Nature Medicine.
The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have produced an updated consensus statement on how to manage hyperglycaemia (high blood sugar) in patients with type 2 diabetes.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
A study led by a UAB oncologist finds that adolescents and young adults with a form of leukemia are disposed to higher relapse rates.
Los investigadores de Mayo Clinic crearon un recurso genético para pronóstico del síndrome mielodisplásico (SMD). Los resultados se publican en la edición impresa correspondiente al mes de octubre de Mayo Clinic Proceedings.
Clinical trial to test potential for blood-based biopsies to identify cancer patients more likely to response to treatment with immunotherapy
روتشستر، مينيسوتا – طوّر الباحثون لدى Mayo Clinic أداة تكهنية جديدة تعتمد على الجينات للتكهن بمتلازمات خلل التنسج النقوي (MDS). ومن المقرر أن تنشر نتائج اكتشافهم في عدد أكتوبر المطبوع من مجلة أحداث Mayo Clinic.
Mayo Clinic的研究人员开发了一种新的基于遗传学的骨髓增生异常综合征（myelodysplastic syndrome，MDS）预后工具。 他们的研究结果发表在10月份的Mayo Clinic Proceedings杂志的印刷版上。
Pesquisadores da Mayo Clinic desenvolveram uma nova ferramenta de prognóstico com base em genética para a síndrome mielodisplástica (MDS). As descobertas da equipe foram publicadas na edição de outubro da Mayo Clinic Proceedings.
Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis (HLH) report in a new study that extra care should be taken to ensure an HLH diagnosis doesn’t obscure possible underlying cancers. They caution in the journal Pediatric Blood & Cancer that expediting HLH treatment may miss underlying malignancies that could end up being fatal to the patient.
Researchers at Mayo Clinic have developed a new genetics-based prognostic tool for myelodysplastic syndrome. Their findings are published in the October print issue of Mayo Clinic Proceedings.
Results may lead to better management of complex eye condition
Loyola University Chicago and Loyola Medicine have announced plans to become the first Chicago center to produce cancer-fighting CAR-T cells to treat leukemia and lymphoma. Loyola plans to produce a more purified CAR-T cell that could reduce toxicities and costs.
UCI School of Medicine researchers have been awarded a $3.4 million grant by the National Cancer Institute (NCI) as part of the Beau Biden Cancer Moonshot initiative. The funding will support efforts to provide proof of principal data for an entirely new class of cancer killing immunotherapeutics with the potential to treat highly diverse types of cancer, from leukemia to breast cancer.
Chicago (Sep. 25, 2018): The Association of Pediatric Hematology/Oncology Nurses (APHON) has awarded this year’s Dr. Patricia Greene Leadership Award to Kaye Schmidt, MA RN NEA-BC CPHON®. Schmidt was presented with this award at the 42nd Annual APHON Conference and Exhibit, held September 13-15, in Savannah, GA.
Chicago (Sep. 25, 2018) The Association of Pediatric Hematology/Oncology Nurses (APHON) announced the recipients of the 2018 APHON Membership Awards at its 42nd Annual Conference and Exhibit, held September 13-15 in Savannah, GA. APHON Membership Awards recognize members who have shown outstanding achievement in their field.
Chicago (Sep. 25, 2018): The Association of Pediatric Hematology/Oncology Nurses (APHON) has awarded Marilyn J. Hockenberry, PhD RN PPCNP-BC FAAN with the 2018 Dr. Nancy E. Kline Mentoring Award. Hockenberry’s achievement was formally announced at the 42nd Annual APHON Conference and Exhibit, on September 14 in Savannah, GA.
Chicago (Sep. 25, 2018): The Association of Pediatric Hematology/Oncology Nurses (APHON) has presented Genevieve Foley, MSN RN with the 2018 Dr. Casey Hooke Distinguished Service Award. Foley’s achievement was officially announced at the 42nd APHON Annual Conference and Exhibit, held September 13-15 in Savannah, GA. This award is presented to an APHON member who has demonstrated excellence to service and to leadership of APHON.
Hackensack Meridian Health K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center to host an event dedicated to pediatric cancer research and programs on September 28, from 4 p.m. to 8 p.m. Tackle Kids Cancer will take place at iPlay America in Freehold, NJ.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right